After a 2018 high, marijuana stocks are gaining popularity again, but which ones are producing the most green for investors? Here are the charts.
Agency has the authority to carve out an exception to existing laws.
Understanding yourself and the investing environment you are in are keys to avoiding panic brought on by fear.
Nektar dropped 40% on Friday after announcing it had manufacturing issues in two batches of experimental cancer drugs.
Stemline Therapeutics and Flexion Therapeutics both saw their shares climb on positive news developments.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.